- 全部删除
- 您的购物车当前为空
CD96 Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 54.27 kDa and the accession number is A0A2K5TWV6.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 μg | ¥ 493 | 6-8日内发货 | |
10 μg | ¥ 790 | 6-8日内发货 | |
20 μg | ¥ 1,330 | 5日内发货 | |
50 μg | ¥ 2,580 | 5日内发货 | |
100 μg | ¥ 5,170 | 5日内发货 | |
200 μg | ¥ 7,730 | 5日内发货 | |
500 μg | ¥ 16,300 | 5日内发货 | |
1 mg | ¥ 33,700 | 5日内发货 |
生物活性 | Immobilized Cynomolgus CD96, His Tag at 5 μg/ml (100 μl/well) on the plate. Dose response curve for Anti-CD96 Antibody, hFc Tag with the EC50 of 0.73 μg/ml determined by ELISA (QC Test). |
产品描述 | CD96 Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 54.27 kDa and the accession number is A0A2K5TWV6. |
种属 | Cynomolgus |
表达系统 | HEK293 Cells |
标签 | C-His |
蛋白编号 | A0A2K5TWV6 |
别名 | CD96 molecule |
蛋白构建 | Val22-Gly502 |
蛋白纯度 | > 95% as determined by Bis-Tris PAGE |
分子量 | 54.27 kDa (predicted); 80-130 kDa (reducing conditions) |
内毒素 | < 1.0 EU/μg of the protein as determined by the LAL method. |
缓冲液 | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
复溶方法 | Reconstitute the lyophilized protein in distilled water. The product concentration should not be less than 100 μg/ml. Before opening, centrifuge the tube to collect powder at the bottom. After adding the reconstitution buffer, avoid vortexing or pipetting for mixing. |
存储 | It is recommended to store recombinant proteins at -20°C to -80°C for future use. Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots. |
运输方式 | In general, Lyophilized powders are shipping with blue ice. |
研究背景 | The receptors CD96 and TIGIT are expressed on the surface of T and natural killer (NK) cells, and recent studies suggest both play important inhibitory roles in immune function. CD96 has been shown to modulate immune cell activity in mice, with Cd96-/- mice displaying hypersensitive NK-cell responses to immune challenge and significant tumor resistance. The counterbalance between the putative inhibitory CD96 and TIGIT receptors and the activating receptor, CD226, offers unique strategies for immuno-oncology drug development. |